News

OSE Immunotherapeutics Introduces Investor-Focused Newsletter

OSE Immunotherapeutics Introduces Investor-Focused Newsletter

OSE Immunotherapeutics Launches Newsletter for Individual Shareholders

NANTES, France – OSE Immunotherapeutics SA (ISIN: FR0012127173; Mnemo: OSE), a pioneering biotechnology company focused on innovative solutions in immuno-oncology and immuno-inflammation, has unveiled its first edition of a newsletter aimed specifically at individual shareholders and investors, both in France and worldwide.

Fiona Olivier, Chief Corporate Affairs & Investor Relations Officer at OSE Immunotherapeutics, shared her enthusiasm: "This year marks a decade since OSE Immunotherapeutics was listed on Euronext Paris. We are excited to present this new platform of communication to cherish our individual shareholders. Beyond regular updates on our company's developments, this newsletter provides a unique opportunity to highlight our dedicated teams and explore topics that typically go unnoticed in press releases. It also serves as a heartfelt gesture of gratitude towards our supportive investor community."

This newsletter will be published regularly in both French and English, ensuring accessibility for a broader audience. Investors can find the newsletter in the 'Investors' section of the OSE Immunotherapeutics website. To stay updated, shareholders are encouraged to subscribe for future editions.

Understanding OSE Immunotherapeutics

ABOUT OSE IMMUNOTHERAPEUTICS
OSE Immunotherapeutics commits to the development of innovative therapeutic solutions that meet the pressing needs of patients in the realms of immuno-oncology and immuno-inflammation. By partnering with top-tier academic institutions and biopharmaceutical organizations, OSE Immunotherapeutics is on a mission to bring transformative medicines to market for those suffering from serious health conditions. The company operates from locations in Nantes and Paris and is publicly listed on Euronext.

Company Vision and Commitment

With a focus on pioneering first-in-class assets, OSE Immunotherapeutics is dedicated to advancing research that has the potential to redefine treatment paradigms in immunotherapy. Their commitment extends to engaging with the community and enhancing investor relations through informational channels like the recently launched newsletter.

Engaging with Shareholders

The establishment of this newsletter is a step towards fostering closer ties with shareholders. OSE Immunotherapeutics aims to ensure that their investors are kept well-informed and engaged with the company's strategic directions and milestones.

Contact Information for Further Inquiry

For additional information or inquiries, investors can reach out to the following contacts:

Fiona Olivier
fiona.olivier@ose-immuno.com

Sylvie Détry
sylvie.detry@ose-immuno.com

Media Contacts

France Media Contact:
FP2COM
Florence Portejoie
fportejoie@fp2com.fr
+33 6 07 768 283

U.S. Media Contact:
RooneyPartners LLC
Kate Barrette
kbarrette@rooneypartners.com
+1 212 223 0561

Frequently Asked Questions

What is the purpose of the newsletter from OSE Immunotherapeutics?

The newsletter is designed to provide individual shareholders with updates, insights, and appreciation directly from the company.

How often will the newsletter be published?

The newsletter will be published regularly, ensuring timely updates on company developments.

In which languages will the newsletter be available?

The newsletter will be available in both French and English to cater to a broader audience.

How can investors subscribe to the newsletter?

Investors can subscribe to the newsletter through the 'Investors' section of the OSE Immunotherapeutics website.

What are the main therapeutic areas of focus for OSE Immunotherapeutics?

OSE Immunotherapeutics focuses on developing assets in immuno-oncology and immuno-inflammation therapies.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Comparent Unveils Key Insights with Top 100 List

Updated Category News Views 8

The Ebb and Flow of Vacation Rental Giants Ever noticed how some industries just sneak up and suddenly transform landscapes? Vacation rental management is one of those sneaky offenders. At the forefront of keeping tabs on this bustling sector, Comparent just dropped a meaty second annual roster—the Comparent 100—showcasing the biggest players flexing their muscles in...

Continue Reading
Karen Love's Retirement Marks End of an Era for TACHP

Updated Category News Views 4

A Legacy Not Just Built, But Carved in Stone In the world of healthcare, folks like Karen Love don’t come around too often. She's stepping down from her post as President and CEO of Cook Children's Health Plan this month, and it feels like the end of a chapter for the Texas Association of Community Health Plans (TACHP). Love wasn't just an executive; she was a mover and...

Continue Reading
Quorum Joins LIVE Coalition to Revolutionize Estate Planning

Updated Category News Views 5

Shaking Up Estate Planning: Quorum Joins LIVE Coalition Here's a fresh shake-up in the world of estate planning. Quorum Federal Credit Union has thrown its hat into the ring as the latest member of the LIVE Coalition, a band of financial, legal, and tech wizards putting estate plans on a modern track. This marks them as the 70th player to dive into this alliance, pushing...

Continue Reading
SaponiQ Reinvents Body Care with Botanical Soap Bars

Updated Category News Views 4

Breaking Through with Simple Innovation I'll be the first to say it's not every day you hear about a soap company trying to shake things up in body care like it’s a tech startup, but here’s SaponiQ taking a wild swing at it with their lineup of botanical cleansing bars. These things are whipped up in their own U.S.-based facility using some fancy cold-process...

Continue Reading
Maternal Health Index: A New Tool With Big Ambitions

Updated Category News Views 7

A Fresh Take on Maternal Health Today's all about the Heartland Forward's fresh tool, the Maternal Resiliency Index. It's making a splash at the 2026 Heartland Summit with a lot of promise on its shoulders. Backed by economists and health gurus like Emily Oster and Dr. Neel Shah, this index ain't your run-of-the-mill tool. It's here to shake the couch coins out of...

Continue Reading
New Tools Arm Manufacturers in Additive Arena

Updated Category News Views 3

Diving Headfirst into Additive Manufacturing Standards Additive manufacturing (AM)—it's not just another tech buzzword. It's revolutionizing everything from life-saving medical devices to cutting-edge aerospace components. But as with any game-changing innovation, there's a wild west era before standards reign in the chaos. Enter ANSI and America Makes, offering new...

Continue Reading
Haystack MRD Shines in Colorectal Cancer Trials

Updated Category News Views 8

A New Dawn in Cancer Detection Just when you think you've seen it all in cancer diagnostics, Haystack MRD® pops up like a fresh tulip in spring. And listen, this ain't just fluff—the results from the DYNAMIC trials are a pretty compelling love letter to the power of liquid biopsy. With 100% specificity and sensitivity hitting a whopping 83.3% over five years, it’s...

Continue Reading
Texas A&M-San Antonio's Research Expansion Momentum

Updated Category News Views 4

Texas A&M-San Antonio's Rising Research Ambitions A rainy day in San Antonio and Texas A&M University-San Antonio seems to have set the stage for more than just another semester of record enrollment. They’ve just rolled in with an exhilarating $8 million in external grants this fiscal year, more than doubling last year’s haul of $3.6 million, in a bid to push their...

Continue Reading
Varda Space's Dual Launch Signals Orbital Ambitions

Updated Category News Views 6

It's not every day you see two commercial rockets heading to orbit on the same ride, but that's precisely what Varda Space Industries just pulled off. With the W-8 and W-9 vehicles blasting off together, Varda is positioning itself for a leap in orbital operations. They've hitched a ride aboard SpaceX's Transporter-18 mission, and this is more than just a double...

Continue Reading
Nukleus Launches Unified Platform for Athletes' Business

Updated Category News Views 7

Leveling the Business Field for Athletes Athletes spend their lives fighting for every inch on the field, and now Nukleus is giving them the tools to hold ground off it. Why should they be the last ones to know their own business? Ashton Jeanty and Nukleus got tired of that narrative and kicked off a platform today with a real promise: putting an athlete's entire business...

Continue Reading

Top 5 Most Recently Viewed Articles

ONEOK Expands Control Over Delaware Basin Operations

Updated Category News Views 161

ONEOK Strengthens Delaware Basin Investment ONEOK, Inc. (NYSE: OKE) has embarked on a significant strategic move by acquiring the remaining 49.9% interest in Delaware G&P LLC, marking a pivotal advancement in their operations within the Delaware Basin. The acquisition, valued at a staggering $940 million, includes $530 million in cash alongside $410 million in common...

Continue Reading
Mary Beth Kingston Joins Kontakt.io's Advisory Board to Innovate

Updated Category News Views 136

Mary Beth Kingston's Impact on Healthcare Technology Kontakt.io, a leader in healthcare Real-Time Location Systems (RTLS) and digital transformation, has welcomed Mary Beth Kingston to its Healthcare Advisory Board. With a remarkable career spanning over 40 years, Kingston is a notable advocate for nurse safety and wellbeing. Her expertise will be instrumental in...

Continue Reading
Consumers Embrace Strategic Spending This BFCM Season

Updated Category News Views 214

Understanding Consumer Spending Trends for Black Friday and Cyber Monday As the holiday shopping season approaches, U.S. consumers are stepping up their spending game. Even with rising inflation and economic uncertainty, numerous studies show that shoppers are set to increase their budgets significantly for Black Friday and Cyber Monday sales. This year, shoppers are...

Continue Reading
Christopher Kuehn Joins Celanese Board Enhancing Leadership

Updated Category News Views 173

Christopher Kuehn Elected to Celanese Board of Directors Celanese Corporation (NYSE: CE), a leading player in the global chemical and specialty materials industry, recently appointed Christopher Kuehn to its Board of Directors. Kuehn is currently the Executive Vice President and Chief Financial Officer of Trane Technologies plc, well-known for its innovative climate...

Continue Reading
Organic Spirulina Market Forecast: Growth and Opportunities Ahead

Updated Category News Views 181

Organic Spirulina Market on the Rise The organic spirulina market is set to witness remarkable growth, with projections estimating it will reach $515 million by 2035. This surge reflects an impressive compound annual growth rate (CAGR) of 13.5%, driven primarily by a growing consumer preference for clean-label products and the premium health benefits they offer....

Continue Reading